Sort   by:  
 Page size 
UnknownSevere oligomeric tau toxicity can be reversed without long-term sequelae.
Not available
S-EPMC8041046 | biostudies-literature
UnknownCo-expression of truncated and full-length tau induces severe neurotoxicity.
Not available
S-EPMC5116481 | biostudies-literature
UnknownUpdate on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Not available
S-EPMC10770020 | biostudies-literature
UnknownLongitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
Not available
S-EPMC5679418 | biostudies-literature
UnknownApheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Not available
S-EPMC12322437 | biostudies-literature
UnknownBaseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).
Not available
S-EPMC4724309 | biostudies-literature
UnknownDiagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Not available
S-EPMC4575273 | biostudies-literature
UnknownInterleukin-2 therapy in patients with HIV infection.
Not available
S-EPMC2869083 | biostudies-literature
UnknownDevelopment and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Not available
S-EPMC4380415 | biostudies-literature
UnknownSeverity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077 | biostudies-literature
Sort   by:  
 Page size